Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Houston, TX

22 studies for Crohn's Disease are recruiting at 36 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Houston

Showing 22 studies, nearest first.
  1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Kelsey Research Foundation (Houston, TX); MedCare Pharma LLC (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  2. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Integrity Advanced Therapeutics /ID# 283871 (Houston, TX); Novel Research - Bellaire /ID# 280925 (Bellaire, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: The University of Texas Health Science Center at Houston (Houston, TX); GI Alliance - Webster (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Baylor College of Medicine Medical Center ( Site 5020) (Houston, TX); Michael E. DeBakey VA Medical Center ( Site 5086) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Integrity Advanced Therapeutics PLLC (Houston, TX); TDDC GI Alliance research Webster (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Mirador Therapeutics Selected Site (Houston, TX); Mirador Therapeutics Selected Site (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

    NCT04372108

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: BAMC (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

    NCT04751396

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    NCT04779320

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Texas Children's Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    NCT06226883

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: The University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

    NCT06257706

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Houston Methodist Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Houston Methodist Hospital /ID# 265533 (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Victorium Clinical Research (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    NCT06233461

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Novel Research, LLC (Bellaire, TX); One of a Kind Clinical research Center TX LLC (Kingwood, TX)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

    NCT06456593

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Novel Research, LLC (Bellaire, TX)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. HB-adMSCs for the Treatment of Crohn's Disease

    NCT07077746

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Hope Biosciences Research Foundation (Sugar Land, TX)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: One of a Kind Clinical Research Center TX, LLC-Site Number; 8400125 (Kingwood, TX); Inquest Clinical Research-Site Number: 8400144 (Baytown, TX)

    Distance to nearest recruiting site
    ~23 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  21. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    NCT07483073

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: One of a Kind Clinical Research Center - Kingwood (Kingwood, TX)

    Distance to nearest recruiting site
    ~23 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

    NCT07483099

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: One of a Kind Clinical Research Center - Kingwood (Kingwood, TX)

    Distance to nearest recruiting site
    ~23 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.